<DOC>
	<DOCNO>NCT00532207</DOCNO>
	<brief_summary>To see use teriparatide 12 month increase Bone Mineral Density lumbar spine postmenopausal woman osteoporosis</brief_summary>
	<brief_title>Study Teriparatide Treatment Postmenopausal Women With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Are postmenopausal woman least 55 year old least 2 year postmenopausal time entry trial , give informed consent enter study inform risk , medication , procedure use study . In addition , woman age 60 year indeterminate menopause due premenopausal hysterectomy must postmenopausal status confirm serum FSH level &gt; 30 IU/L . Posterioranterior lumbar spine ( L1L4 ) BMD and/or femoral neck BMD measurement least &lt; 2.5 standard deviation ( SD ) mean healthy , premenopausal woman . Results lumbar BMD ( L1L4 ) measurement must available . The initial lumbar spine assessment determination patient 's eligibility entry screen phase make individual investigator . If L1 vertebra analyze due artifact , vertebral fracture , osteophytes , abnormality , vertebra exclude analysis . Normal clinically insignificant abnormal laboratory value ( define investigator ) include serum calcium , 25 hydroxyvitamin D level alkaline phosphatase . Willing trained use pen type injection delivery system daily basis 12 month . Active liver disease liver enzymes ( ALT , AST ) three time upper normal range , bilirubin &gt; 2.0 mg/dl , clinical jaundice . Abnormal thyroid function correct therapy . Normal thyroid function document normal TSH screen phase History active nephrolithiasis urolithiasis prior 2 year . Patients document history nephro urolithiasis must appropriate imaging procedure within prior 6 month , , intravenous pyelography ( IVP ) , supine radiograph kidney ureter bladder ( KUB ) , renal ultrasound , must document absence stone History malignant neoplasm within prior 5 year , exception superficial basal cell carcinoma squamous cell carcinoma skin definitively treat . If malignant neoplasm ever diagnose , patient must presently free disease . Current pharmacological treatment osteoporosis , calcium Vitamin D History Paget 's disease , renal osteodystrophy , osteomalacia , secondary cause osteoporosis , hyperparathyroidism ( uncorrected ) , intestinal malabsorption</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>